Last reviewed · How we verify
MEDI7352 for Subcutaneous Injection
At a glance
| Generic name | MEDI7352 for Subcutaneous Injection |
|---|---|
| Sponsor | AstraZeneca |
| Modality | Biologic |
| Phase | Phase 1 |
Approved indications
Common side effects
Key clinical trials
- Evaluate Safety, Tolerability, Pharmacokinetics and Immunogenicity of MEDI7352 in Healthy Volunteers (PHASE1)
- A Study of MEDI7352 in Painful Osteoarthritis of the Knee (PHASE1)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |